Older individuals suffering from complications of type 2 diabetes are at increased risk of falling, researchers found.

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.

DexCom, Inc., of San Diego, announced that it has received approval to calibrate Seven, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter.

WITH 45% of dialysis patients presenting as a result of diabetic kidney disease or with comorbidity of diabetes, studies are examining blood sugar control as a means to improving outcomes for this large segment of the dialysis population.

Amylin Pharmaceuticals, Inc., of San Diego, announced the approval the SymlinPen 120 and the SymlinPen 60 pre-filled pen-injector devices for administering Symlin (pramlintide acetate) to improve mealtime glucose control.

CHICAGO—Diabetes increases the likelihood of UTI recurrences in pre- and post-menopausal women, despite longer treatments with more potent initial antibiotics, a Dutch study shows.

HIGH DOSES of valsartan reduce albuminuria to a greater extent than the conventional 160 mg dose in type 2 diabetics, researchers concluded.

ELEVATED LEVELS of inflammatory cytokines in the blood can predict type 2 diabetes in menopausal women years before the disease manifests itself, according to a large study.

MODERATE COFFEE consumption is associated with a reduced risk of having diabetes, according to researchers in Greece. The findings come from a study of 500 men and 437 women (aged 65-100 years) from Cyprus, Crete, and other Mediterranean islands.